Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status

Journal of Nutritional Biochemistry

Volumn 24, Issue 11, 2013, Pages 1840-1848

  Spilmont, Mélanie ^a,b,c,f   Léotoing, Laurent ^a,b,c   Davicco, Marie Jeanne ^a,b,c   Lebecque, Patrice ^a,b,c   Mercier, Sylvie ^a,b,c   Miot Noirault, Elisabeth ^c,d   Pilet, Paul ^d,e   Rios, Laurent ^f   Wittrant, Yohann ^a,b,c   Coxam, Véronique ^a,b,c  

^a CRNH AUVERGNE   (France)

^b Equipe Alimentation   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d INSERM   (France)

^e Laboratoire d'Acoustique Environnementale)   (France)

^f Greentech naturally   (France)

Author keywords

Animal model; Cell lines; Nutritional prevention; Osteoporosis; Pomegranate seed oil

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA CATENIN; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ANTAGONIST; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; POMEGRANATE EXTRACT; POMEGRANATE SEED OIL; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VEGETABLE OIL; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE TISSUE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STIMULATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EX VIVO STUDY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPENIA; OVARIECTOMY; POMEGRANATE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRABECULAR BONE;

ANIMALIA; LYTHRACEAE; MUS;

ANIMAL MODEL; CELL LINES; NUTRITIONAL PREVENTION; OSTEOPOROSIS; POMEGRANATE SEED OIL;

ANIMALS; BONE DENSITY; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; LINOLENIC ACIDS; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; PLANT OILS; PUNICACEAE; RECEPTORS, INTERLEUKIN-6; SEEDS;

EID: 84885844255     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.04.005     Document Type: Article

References (55)

1. Schulman R.C., Weiss A.J., Mechanick J.I. Nutrition, bone, and aging: an integrative physiology approach. Curr Osteoporos Rep 2011, 9:184-195.
2. Mundy G.R. Osteoporosis: pathophysiology and non-pharmacological management. Best Pract Res Clin Rheumatol 2001, 15:727-745.
3. Gallagher J.C., Sai A.J. Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas 2010, 65:301-307.
4. Kular J., Tickner J., Chim S.M., Xu J. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem 2012, 45:863-873.
5. Lacativa P.G., Farias M.L. Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 2010, 54:123-132.
6. Shen C.L., Yeh J.K., Cao J.J., Chyu M.C., Wang J.S. Green tea and bone health: evidence from laboratory studies. Pharmacol Res 2011, 64:155-161.
7. Cagnetta V., Patella V. The role of the immune system in the physiopathology of osteoporosis. Clinical cases in mineral and bone metabolism: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. 2012, 9:85-88.
8. Laneuville O., Breuer D.K., Xu N., Huang Z.H., Gage D.A., Watson J.T., et al. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z,13E/Z,15Z)-octadecatrienoic acids from alpha-linolenic acid. J Biol Chem 1995, 270:19330-19336.
9. Raisz L.G., Alander C.B., Simmons H.A. Effects of prostaglandin E3 and eicosapentaenoic acid on rat bone in organ culture. Prostaglandins 1989, 37:615-625.
10. Albertazzi P., Coupland K. Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?. Maturitas 2002, 42:13-22.
11. Kruger M.C., Coetzee M., Haag M., Weiler H. Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Prog Lipid Res 2010, 49:438-449.
12. Poulsen R.C., Moughan P.J., Kruger M.C. Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med 2007, 232:1275-1288. Maywood, NJ.
13. Salari P., Rezaie A., Larijani B., Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008, 14:RA37-RA44.
14. Watkins B.A., Li Y., Lippman H.E., Feng S. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids 2003, 68:387-398.
15. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008, 20:429-434.
16. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98:251-266.
17. Reid D.M. Relationships between fat and bone. Osteoporos Int 2008, 19:595-606.
18. Rosen C.J. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009, 122:409-414.
19. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract 2006, 2:35-43.
20. Hwang D.M., Kundu J.K., Shin J.W., Lee J.C., Lee H.J., Surh Y.J. cis-9,trans-11-Conjugated linoleic acid down-regulates phorbol ester-induced NF-κB activation and subsequent COX-2 expression in hairless mouse skin by targeting IκB kinase and PI3K-Akt. Carcinogenesis 2007, 28:363-371.
21. Nagao K., Yanagita T. Conjugated fatty acids in food and their health benefits. J Biosci Bioeng 2005, 100:152-157.
22. Hernandez F., Melgarejo P., Olias J.M., Atres F. Fatty acid composition and total lipid content of seed oil from three commercial pomegranate cultivars. CIHEAM - Options Mediterraneennes 2000.
23. Boussetta T., Raad H., Letteron P., Gougerot-Pocidalo M.A., Marie J.C., Driss F., et al. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One 2009, 4:e6458.
24. Hontecillas R., O'Shea M., Einerhand A., Diguardo M., Bassaganya-Riera J. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr 2009, 28:184-195.
25. Lansky E.P., Newman R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 2007, 109:177-206.
26. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
27. Ledoux M., Chardigny J.M., Darbois M., Soustre Y., Sébédio J.L., Laloux L. Fatty acid composition of French butters, with special emphasis on conjugated linoleic acid (CLA) isomers. Journal of Food Composition and Analysis 2005, 18:409-425.
28. Sabokbar A., Millett P.J., Myer B., Rushton N. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner 1994, 27:57-67.
29. Trzeciakiewicz A., Habauzit V., Mercier S., Barron D., Urpi-Sarda M., Manach C., et al. Molecular mechanism of hesperetin-7-O-glucuronide, the main circulating metabolite of hesperidin, involved in osteoblast differentiation. J Agric Food Chem 2010, 58:668-675.
30. Wittrant Y., Gorin Y., Woodruff K., Horn D., Abboud H.E., Mohan S., et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 2008, 42:1122-1130.
31. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991, 15:175-191.
32. Lei Z., Xiaoying Z., Xingguo L. Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int J Exp Pathol 2009, 90:512-519.
33. Duque G., Huang D.C., Dion N., Macoritto M., Rivas D., Li W., et al. Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res 2011, 26:1472-1483.
34. Kim T.H., Jung J.W., Ha B.G., Hong J.M., Park E.K., Kim H.J., et al. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J Nutr Biochem 2011, 22:8-15.
35. Banu J., Varela E., Bahadur A.N., Soomro R., Kazi N., Fernandes G. Inhibition of bone loss by Cissus quadrangularis in mice: a preliminary report. J Osteoporos 2012, 2012:101206.
36. Tsuzuki T., Kawakami Y., Abe R., Nakagawa K., Koba K., Imamura J., et al. Conjugated linolenic acid is slowly absorbed in rat intestine, but quickly converted to conjugated linoleic acid. J Nutr 2006, 136:2153-2159.
37. Brownbill R.A., Petrosian M., Ilich J.Z. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J Am Coll Nutr 2005, 24:177-181.
38. Park Y., Pariza M.W. Cosupplementation of dietary calcium and conjugated linoleic acid (CLA) improves bone mass in mice. J Food Sci 2008, 73:C556-C560.
39. Rahman M.M., Halade G.V., Williams P.J., Fernandes G. t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity. J Cell Physiol 2011, 226:2406-2414.
40. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
41. Rahman M.M., Bhattacharya A., Fernandes G. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. J Lipid Res 2006, 47:1739-1748.
42. Platt I., El-Sohemy A. Effects of 9cis,11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes. Lipids Health Dis 2009, 8:15.
43. Zhang C. Molecular mechanisms of osteoblast-specific transcription factor Osterix effect on bone formation. Zhang C 2012, 44:659-665.
44. Zhang Y., Su J., Yu J., Bu X., Ren T., Liu X., et al. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J Bone Miner Res 2011, 26:604-617.
45. Zhang R., Oyajobi B.O., Harris S.E., Chen D., Tsao C., Deng H.W., et al. Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2012, 52:145-156.
46. Kim J., Park Y., Lee S.H. trans-10,cis-12 Conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator activated receptor-gamma-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells. J Nutr Biochem 2012.
47. Platt I.D., El-Sohemy A. Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid. J Nutr Biochem 2009, 20:956-964.
48. Redlich K., Smolen J.S. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 2012, 11:234-250.
49. Asghari G., Sheikholeslami S., Mirmiran P., Chary A., Hedayati M., Shafiee A., et al. Effect of pomegranate seed oil on serum TNF-alpha level in dyslipidemic patients. Int J Food Sci Nutr 2012, 63:368-371.
50. Bassaganya-Riera J., Guri A.J., Hontecillas R. Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists. J Obes 2011, 2011:897894.
51. Saha S.S., Dasgupta P., Sengupta Bandyopadhyay S., Ghosh M. Synergistic effect of conjugated linolenic acid isomers against induced oxidative stress, inflammation and erythrocyte membrane disintegrity in rat model. Biochim Biophys Acta 1820, 2012:1951-1970.
52. Grossmann M.E., Mizuno N.K., Schuster T., Cleary M.P. Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int J Oncol 2010, 36:421-426.
53. Saha S.S., Ghosh M. Antioxidant and anti-inflammatory effect of conjugated linolenic acid isomers against streptozotocin-induced diabetes. Br J Nutr 2012, 108:974-983.
54. Wauquier F., Leotoing L., Coxam V., Guicheux J., Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol Med 2009, 15:468-477.
55. Lioret S., Touvier M., Dubuisson C., Dufour A., Calamassi-Tran G., Lafay L., et al. Trends in child overweight rates and energy intake in France from 1999 to 2007: relationships with socioeconomic status. Obesity (Silver Spring) 2009, 17:1092-1100.